San Rafael, CA, United States of America

Kris Antonsen

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Innovations by Kris Antonsen: Advancements in Biochemistry

Introduction

Kris Antonsen, an accomplished inventor based in San Rafael, California, has made significant contributions to the field of biochemistry with her innovative work. With a total of two patents to her name, she focuses on enhancing the efficiency and safety of enzymatic processes, particularly through her research on prokaryotic phenylalanine ammonia-lyase variants.

Latest Patents

Antonsen's most recent patents involve the compositions and methods related to prokaryotic phenylalanine ammonia-lyase (PAL) variants. These prokaryotic PAL variants demonstrate greater phenylalanine-converting activity and reduced immunogenicity when compared to their wild-type counterparts. The disclosed compositions also include biologically active fragments, mutants, variants, or analogs, alongside methodologies for their production, purification, formulation, and application in various industrial and therapeutic contexts. Notably, these compositions can play a critical role in treating hyperphenylalaninemia, including phenylketonuria, as well as other serious health disorders, such as cancer.

Career Highlights

Kris Antonsen is a key contributor at Biomarin Pharmaceutical Inc., where she employs her expertise to drive innovations in the pharmaceutical sector. Her work not only advances the field of enzymatic biology but also contributes to the development of therapeutic solutions that improve patient outcomes.

Collaborations

Throughout her career, Antonsen has collaborated with renowned colleagues, such as Augustus O. Okhamafe and Sean M. Bell. These partnerships enhance her research capabilities and expand the impact of her discoveries within the scientific community.

Conclusion

Kris Antonsen stands out as a dynamic inventor in the biochemistry space, particularly in her advancements related to phenylalanine ammonia-lyase variants. Her patents demonstrate a promising direction for therapeutic advancements and reflect her ongoing commitment to the development of innovative solutions within the pharmaceutical industry. As her work continues to evolve, the implications for treating metabolic disorders and cancer remain profound.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…